Kovack Advisors’s NEVRO CORP. NVRO Stock Holding History

Kovack Advisors’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,700	Closed	-$547K	–	773
2021 Q3	$547K	Buy	+4,700	New	+$615K	0.06%	359

Other funds holding NVRO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kovack Advisors's NVRO Position: Q4 2021 in Review

Kovack Advisors sold out of NEVRO CORP. (NVRO) in Q4 2021, closing a stake of 4,700 shares — an estimated $547K sold.

Kovack Advisors first reported a position in NVRO in Q3 2021 and held it in 1 quarter. The position peaked at $547K in Q3 2021. 209 funds tracked by Wall St. Rank hold NVRO as of Q4 2021.

Kovack Advisors reported no remaining NEVRO CORP. position as of Q4 2021 after selling out during the quarter.
Kovack Advisors sold 4,700 NEVRO CORP. shares in Q4 2021, an estimated $547K.
Kovack Advisors first reported a position in NEVRO CORP. in Q3 2021 and held it in 1 quarter.
Kovack Advisors's NEVRO CORP. position peaked at $547K in Q3 2021.
209 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2021.

Based on Kovack Advisors's 13F filing for Q4 2021, filed 18 Jan 2022.